Bill > SB207

This bill amends New Mexico's Prior Authorization Act to expand the types of medical conditions for which prescription drugs cannot be subject to prior authorization or step therapy requirements. Specifically, the bill adds "rare diseases" to the existing list of conditions (autoimmune disorders, cancer, and substance use disorders) that are exempt from prior authorization and step therapy protocols. The bill defines a "rare disease" as a medical condition that affects fewer than 200,000 people in the United States. The amendment also clarifies that the exemption applies to both on-label and off-label drug uses, meaning the medications can be prescribed for their FDA-approved purpose or for alternative medical uses determined to be medically necessary. This change aims to reduce administrative barriers for patients seeking treatment for less common medical conditions, ensuring that they can more quickly access potentially life-changing medications without having to first go through lengthy prior authorization or step therapy processes.

Health and Social Services

https://www.nmlegis.gov/Legislation/Legislation?chamber=S&legtype=B&legno=207&year=25